Clinical Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2007; 13(33): 4473-4479
Published online Sep 7, 2007. doi: 10.3748/wjg.v13.i33.4473
Table 1 Tie and Ang immunohistochemistry in intestinal stromal tumors n (%)
Ang-1
Ang-2
Ang-4
Tie-1
Tie-2
n-+-+-+-+-+
GIST3010 (33.3)20 (66.7)5 (16.7)25 (83.3)19 (63.3)11 (36.7)12 (40.0)18 (60.0)27 (90.0)3 (10.0)a
Leiomyoma174 (23.5)13 (76.5)3 (17.6)14 (82.4)7 (41.2)10 (58.8)3 (17.6)14 (82.4)1 (5.9)16 (94.1)
Schwannoma61 (16.7)5 (83.3)0 (0.0)6 (100)1 (16.7)5 (83.3)0 (0.0)6 (100)4 (66.7)2 (33.3)
Table 2 Tie and Ang expression and risk categories for GISTs (30 cases) n (%)
Ang-1
Ang-2
Ang-4
Tie-1
Tie-2
n-+-+-+-+-+
GIST3010 (33.3)20 (66.7)5 (16.7)25 (83.3)19 (63.3)11 (36.7)12 (40.0)18 (60.0)27 (90.0)3 (10.0)
Risk categoriesNSNSNSNSNS
High61 (16.7)5 (83.3)2 (33.3)4 (66.7)6 (100)0 (0.0)1 (16.7)5 (83.3)5 (83.3)1 (16.7)
Intermediate42 (50.0)2 (50.0)1 (25.0)3 (75.0)2 (50.0)2 (50.0)2 (50.0)2 (50.0)4 (100)0 (0.0)
Low156 (40.0)9 (60.0)2 (13.3)13 (86.7)8 (53.3)7 (46.7)5 (33.3)10 (66.7)13 (86.7)2 (13.3)
Very low51 (20.0)4 (80.0)0 (0.0)5 (100)3 (60.0)2 (40.0)4 (80.0)1 (20.0)5 (100)0 (0.0)
Mitosis counts (per 50 fields, HPF)NSNSNSNSNS
< 2197 (36.8)12 (63.2)3 (15.8)16 (84.2)11 (57.9)8 (42.1)9 (47.4)10 (52.6)17 (89.5)2 (10.5)
2-572 (28.6)5 (71.4)1 (14.3)6 (85.7)4 (57.1)3 (42.9)2 (28.6)5 (71.4)6 (85.7)1 (14.3)
6-1021 (50.0)1 (50.0)1 (50.0)1 (50.0)2 (100)0 (0.0)0 (0.0)2 (100)2 (100)0 (0.0)
10 <20 (0.0)2 (100)0 (0.0)2 (100)2 (100)0 (0.0)1 (50.0)1 (50.0)2 (100)0 (0.0)
Tumor size (cm in length)NSNSNSNSNS
< 241 (25.0)3 (75.0)0 (0.0)4 (100)3 (75.0)1 (25.0)3 (75.0)1 (25.0)4 (100)0 (0.0)
2-5166 (37.5)10 (62.5)2 (12.5)14 (87.5)9 (56.3)7 (43.8)6 (37.5)10 (62.5)15 (93.8)1 (6.3)
5-1073 (42.9)4 (57.1)2 (28.6)5 (71.4)4 (57.1)3 (42.9)2 (28.6)5 (71.4)6 (85.7)1 (14.3)
> 1030 (0.0)3 (100)1 (33.3)2 (66.7)3 (100)0 (0.0)1 (33.3)2 (66.7)2 (66.7)1 (33.3)